Rechercher ( 10057 résultats )
- article
(Mis à jour le )
2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals
While influenza vaccines aim to decrease the incidence of severe influenza among high-risk groups, evidence of influenza vaccine effectiveness (IVE) among the influenza vaccine target...
- article
(Mis à jour le )
A pilot validation in 10 European Union member states of a point prevalence survey of healthcare-associated infections and antimicrobial use in acute hospitals in Europe, 2011
We present a pilot validation study performed on 10 European Union (EU) Member States, of a point prevalence survey (PPS) of healthcare-associated infections (HAIs) and antimicrobial use...
- article
(Mis à jour le )
Progressing towards tuberculosis elimination in the European Union and European Economic Area
- article
(Mis à jour le )
High-level azithromycin-resistant Neisseria gonorrhoeae clinical isolate in France, March 2014
We report the first case in France of a high-level azithromycin-resistant Neisseria gonorrhoeae (minimum inhibitory concentration (MIC) = 96 mg/L) assigned to MLST7363 (NG-MAST ST6360),...
- article
(Mis à jour le )
Incidence and hospitalisation rates of Lyme borreliosis, France, 2004 to 2012
Lyme borreliosis (LB) has become a major concern recently, as trends in several epidemiological studies indicate that there has been an increase in this disease in Europe and America...
- article
(Mis à jour le )
Epidemiology of tuberculosis in big cities of the European Union and European Economic Area countries
This cross-sectional survey aimed to examine the epidemiology of tuberculosis (TB) in European Union (EU) and European Economic Area (EEA) cities with populations greater than 500,000....
- article
(Mis à jour le )
Tuberculosis control in big cities and urban risk groups in the European Union: a consensus statement
In low-incidence countries in the European Union (EU), tuberculosis (TB) is concentrated in big cities, especially among certain urban high-risk groups including immigrants from TB...
- article
(Mis à jour le )
10 years of surveillance of human tularaemia in France
Tularaemia has been mandatorily notifiable in France since October 2002. The surveillance aims to detect early any infection possibly due to bioterrorism and to follow up disease trends....
- article
(Mis à jour le )
Negative impact of HBV/HCV coinfection on HBV or HCV monoinfection: Data from the French cohort ANRS CO22 hepather
- article
(Mis à jour le )
Relationship between HCV genotype, liver co-morbidities and fibrosis in the French cohort ANRS CO22 HEPATHER
